IDIV-B:CA:TSX-Manulife Smart International Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 13.71

Change

+0.07 (+0.51)%

Market Cap

N/A

Volume

800.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.02 (+0.03%)

CAD 5.29B
PHYS-U:CA Sprott Physical Gold Trust

+0.17 (+0.87%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.35 (+1.00%)

CAD 4.54B
XEQT:CA iShares Core Equity Portfolio

+0.31 (+0.99%)

CAD 4.46B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.38 (+1.65%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.29 (+3.00%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.03 (+0.14%)

CAD 2.52B

ETFs Containing IDIV-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.01% 66% D+ 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.01% 64% D 54% F
Trailing 12 Months  
Capital Gain 14.35% 59% D- 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.35% 57% F 52% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.53% 73% C 58% F
Dividend Return 5.53% 73% C 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.64% 59% D- 81% B-
Risk Adjusted Return 83.25% 95% A 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike